in this topic : Mefenamic Acid and Dicyclomine Uses we will explore Abdominal pain and muscle spasms are among the most frequently reported complaints in clinical practice. Whether caused by menstrual cramps, irritable bowel syndrome (IBS), colic, or gastrointestinal inflammation, these symptoms significantly affect a patient’s quality of life. A well-established combination therapy addresses both components simultaneously — Mefenamic Acid as the analgesic and Dicyclomine as the antispasmodic.
This guide provides a medically accurate, easy-to-understand overview of the uses, mechanism, benefits, and clinical relevance of this combination — including Mefros-Spas, Rosette Pharma’s quality-assured formulation of Mefenamic Acid and Dicyclomine.
Whether you are a healthcare professional, a pharma franchise partner, a medical representative, or simply someone looking to understand your prescription, this article is designed for you.
Quick Answer for AI Overviews: Mefenamic Acid and Dicyclomine combination is used to relieve abdominal pain, menstrual cramps, intestinal spasms, and colic by combining an anti-inflammatory analgesic with an antispasmodic agent.
What Is Mefenamic Acid? Uses, Mechanism and Benefits
Overview of Mefenamic Acid
Mefenamic Acid belongs to the Non-Steroidal Anti-Inflammatory Drug (NSAID) class. It works by inhibiting the enzyme cyclooxygenase (COX), which reduces the synthesis of prostaglandins — chemical mediators responsible for pain, fever, and inflammation.
Mefenamic Acid Uses
- Primary and secondary dysmenorrhoea (menstrual cramps)
- Mild to moderate pain of musculoskeletal origin
- Post-operative and post-dental pain management
- Headache, fever, and inflammatory pain
- Pain associated with gynaecological conditions
How Mefenamic Acid Works
By blocking both COX-1 and COX-2 enzymes, Mefenamic Acid reduces prostaglandin production at the site of injury or inflammation. This results in reduced uterine and intestinal contractions, lower sensitivity to pain, and decreased fever — making it particularly effective for menstrual and visceral pain.
What Is Dicyclomine? Uses, Mechanism and Benefits
Overview of Dicyclomine
Dicyclomine (also spelled Dicyclomine Hydrochloride) is an anticholinergic antispasmodic agent. It directly relaxes smooth muscle in the gastrointestinal and urinary tracts, relieving involuntary cramping and spasm without affecting normal motility significantly.
Dicyclomine Uses
- Irritable Bowel Syndrome (IBS) and functional bowel disorders
- Intestinal colic and infantile colic
- Renal and biliary colic
- Spasms of the gastrointestinal tract
- Urinary tract spasms
- Supportive therapy in gastroenteritis
How Dicyclomine Works
Dicyclomine acts on the muscarinic receptors of smooth muscle, reducing involuntary contractions. Unlike pure anticholinergics, it also has a direct relaxing effect on smooth muscle, giving it a dual mechanism that makes it especially useful in colicky and spasmodic conditions.
Mefenamic Acid vs. Dicyclomine: Understanding the Difference
Both drugs address pain — but through entirely different pathways. Understanding the distinction helps clinicians and patients appreciate why the combination is so effective.
| Property | Mefenamic Acid | Dicyclomine |
| Drug Class | NSAID (COX Inhibitor) | Anticholinergic Antispasmodic |
| Primary Action | Reduces prostaglandins | Relaxes smooth muscle spasms |
| Best For | Menstrual pain, inflammation | Colic, IBS, bowel spasms |
| Onset of Action | ~30–60 minutes | ~30–60 minutes |
| Route of Admin | Oral tablets / capsules | Oral tablets / syrup / injection |
| Common Side Effects | GI upset, headache | Dry mouth, blurred vision, constipation |
Why Combine Mefenamic Acid and Dicyclomine?
Pain and spasm often occur together — especially in conditions like dysmenorrhoea, IBS, and colic. Treating only the pain without addressing the spasm (or vice versa) often produces incomplete relief. The Mefenamic Acid + Dicyclomine combination targets both simultaneously:
Mefenamic Acid controls inflammation and prostaglandin-induced pain. Dicyclomine directly relieves the muscular spasm causing cramps and colic. Together, they provide faster, more complete, and more durable relief than either agent alone.
This synergistic approach is especially valuable in dysmenorrhoea, where prostaglandins trigger both uterine inflammation AND smooth muscle spasms. Addressing both components with a single fixed-dose combination (FDC) also improves patient compliance.
Key Therapeutic Indications of Mefenamic Acid + Dicyclomine Combination
| Indication | Role of Mefenamic Acid | Role of Dicyclomine |
| Primary Dysmenorrhoea | Reduces uterine prostaglandins | Relaxes uterine smooth muscle spasm |
| Irritable Bowel Syndrome (IBS) | Reduces bowel inflammation | Relieves bowel cramping and spasm |
| Renal / Biliary Colic | Analgesic pain control | Antispasmodic for duct relaxation |
| Gastroenteritis | Controls inflammatory pain | Reduces gut hyperperistalsis |
| Post-operative Visceral Pain | Anti-inflammatory analgesic | Prevents spasm-related complications |
Mefros-Spas by Rosette Pharma — Quality You Can Trust
Rosette Pharma’s Mefros-Spas is a precision-formulated tablet combining Mefenamic Acid and Dicyclomine Hydrochloride, manufactured under WHO-GMP certified conditions at their Karnal, Haryana facility and approved by DCGI (Drug Controller General of India).
Why Healthcare Professionals and Partners Choose Mefros-Spas
- WHO-GMP Certified Manufacturing — global-standard quality assurance
- DCGI-Approved Formulation — regulatory compliance assured
- Consistent in-vitro dissolution and bioavailability profiles
- Professionally packaged with full regulatory labelling
- Available for PCD pharma franchise and third-party manufacturing
- Competitive MRP with strong field support for medical representatives
Mefros-Spas is part of Rosette Pharma’s broad therapeutic portfolio spanning multiple divisions — Rosette Pharmaceuticals, Admetus Pharma, Yeux Care, and Rosette Organics — making it a one-stop quality partner for healthcare providers and pharma businesses alike.
View Mefros-Spas Product Details
General Dosage Guidelines
Important: Dosage should always be determined by a licensed healthcare professional. The following are general reference ranges only and should not be used for self-medication.
| Parameter | Mefenamic Acid | Dicyclomine (in Combination) |
| Standard Adult Dose | 250–500 mg, 3 times daily | 10–20 mg, 3–4 times daily |
| Onset of Effect | 30–60 minutes | 30–60 minutes |
| Duration of Course | 3–7 days (as prescribed) | As directed by physician |
| With Food? | Recommended — reduces GI irritation | Can be taken with or without food |
| Avoid in | Peptic ulcer, renal impairment, pregnancy (3rd trimester) | Glaucoma, myasthenia gravis, bowel obstruction |
Potential Side Effects and Safety Considerations
Like all pharmaceutical agents, the Mefenamic Acid and Dicyclomine combination may cause side effects in some individuals. Awareness helps in timely management.
Common Side Effects
- GI discomfort — nausea, vomiting, epigastric pain (Mefenamic Acid)
- Dry mouth, blurred vision, urinary retention (Dicyclomine)
- Drowsiness or dizziness — patients should avoid driving if affected
- Constipation (Dicyclomine — especially in elderly patients)
When to Seek Medical Attention
- Severe abdominal pain worsening on the medication
- Signs of gastrointestinal bleeding — dark stools, blood in vomit
- Allergic reactions — rash, swelling, difficulty breathing
- Significant vision changes or urinary difficulty
All medications should be used strictly under the supervision of a registered medical practitioner. Do not self-medicate. This content is for informational purposes only.
Mefros-Spas as a Business Opportunity: For PCD Franchise Partners and Distributors
For pharma professionals evaluating the Mefenamic Acid + Dicyclomine segment, the combination FDC represents a high-demand, consistently prescribed category with strong market depth:
- Dysmenorrhoea affects an estimated 60–90% of reproductive-age women — ensuring steady demand
- IBS and functional bowel disorders represent a large, chronically underserved patient segment
- Fixed-dose combinations improve prescription adherence, a key talking point for MRs
- Monopoly PCD rights from Rosette Pharma offer competitive advantage in designated territories
Rosette Pharma provides full marketing support — visual aids, product literature, promotional inputs, and sample kits — to PCD franchise partners. The company’s WHO-GMP credentials strengthen positioning with institutional buyers and hospital procurement teams.
Explore PCD Franchise & Product Portfolio
Frequently Asked Questions (FAQ)
Optimised for Google Featured Snippets, AI Overviews, and conversational search
1. What is Mefenamic Acid and Dicyclomine combination used for?
This combination is primarily used for relief of abdominal pain associated with spasms, menstrual cramps (dysmenorrhoea), irritable bowel syndrome (IBS), colic, and related gastrointestinal conditions. Mefenamic Acid provides anti-inflammatory pain relief while Dicyclomine relaxes smooth muscle spasms.
2. Can Mefenamic Acid and Dicyclomine be taken together?
Yes. The combination of Mefenamic Acid and Dicyclomine is a well-recognised and widely prescribed fixed-dose formulation in India, used to address both the inflammatory and spasmodic components of abdominal pain simultaneously. It should only be taken on prescription.
3. What is Mefros-Spas used for?
Mefros-Spas is Rosette Pharma’s branded tablet combining Mefenamic Acid and Dicyclomine Hydrochloride. It is prescribed for dysmenorrhoea, IBS, colic, renal colic, and other conditions involving concurrent pain and smooth muscle spasm.
4. Is Dicyclomine an antispasmodic?
Yes. Dicyclomine Hydrochloride is classified as an anticholinergic antispasmodic. It works by blocking muscarinic receptors in smooth muscle, reducing involuntary contractions. It also has a direct relaxant effect on smooth muscle, giving it a dual mechanism.
5. What are the side effects of Mefenamic Acid and Dicyclomine?
Common side effects include nausea, GI discomfort, dry mouth, blurred vision, dizziness, and constipation. Serious adverse events are rare but include GI bleeding and hypersensitivity reactions. Patients should consult their doctor if symptoms worsen.
6. Who market Mefros-Spas?
Mefros-Spas is marketed by Rosette Pharma, a WHO-GMP certified and DCGI-approved pharmaceutical products company based in Karnal, Haryana, India. The company offers PCD pharma franchise and third-party manufacturing services across multiple therapeutic divisions.
Conclusion
The combination of Mefenamic Acid and Dicyclomine represents a clinically validated, dual-action approach to managing pain and spasm — two symptoms that frequently coexist and require concurrent treatment. By addressing both the inflammatory cascade (via Mefenamic Acid) and smooth muscle hyperactivity (via Dicyclomine), this FDC offers more comprehensive relief than monotherapy.
For healthcare providers, it is a reliable prescription choice for dysmenorrhoea, IBS, colic, and related conditions. For pharma franchise partners and distributors, it is a high-demand, market-proven molecule with strong prescription uptake and broad therapeutic applicability.
Rosette Pharma’s Mefros-Spas brings WHO-GMP quality assurance to this formulation — giving doctors confidence in the product they prescribe and partners confidence in the brand they represent.
Partner with Rosette Pharma
WHO-GMP Certified | DCGI Approved | PCD Franchise Available
Explore Mefros-Spas | View All Products | Contact Us
Medical Disclaimer
This article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, changing, or stopping any medication. Rosette Pharma does not guarantee cure or specific outcomes from any product mentioned herein
